|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61K 31/58 | |||
| A61K 31/7088 | |||
| A61K 38/00 | |||
| A61K 9/00 | |||
| A61K 9/10 | |||
| A61K 9/127 | |||
| A61K 9/19 | |||
| A61P 27/02 |
| (11) | Number of the document | 2813229 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14180435.1 |
| Date of filing the European patent application | 2010-01-29 | |
| (97) | Date of publication of the European application | 2014-12-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 538435 | 2009-08-10 | US |
| (72) |
SHIH, Sheue-Fang, TW
CHANG, Po-Chun, TW
TSENG, Yun-Long, TW
GUO, Luke. , S., S.,, US
HONG, Keelung, US
|
| (73) |
TLC Biopharmaceuticals, Inc.,
432 North Canal Street 20, South San Francisco, CA 94080,
US
Taiwan Liposome Co., Ltd., 11F.-1, No. 3, Yuanqu Street Nangang District, Taipei City 115, TW |
| (54) | Ophthalmic drug delivery system containing phospholipid and cholesterol |
| Ophthalmic drug delivery system containing phospholipid and cholesterol |